Virtu Financial’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Virtu Financial’s Portfolio MDNA Stock Details MDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,086	Closed	-$3K	–	2236
2023 Q3	$3K	Sell	12,086 -9,444	-44%	-$3.67K	﹤0.01%	1172
2023 Q2	$10K	Buy	+21,530	New	+$13.3K	﹤0.01%	1355
2023 Q1	–	Sell	-42,990	Closed	-$20K	–	2339
2022 Q4	$20K	Buy	+42,990	New	+$26.3K	﹤0.01%	1277

Other funds holding MDNA

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

NDSI

Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Virtu Financial's MDNA Position: Q4 2023 in Review

Virtu Financial sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 12,086 shares — an estimated $3K sold.

Virtu Financial first reported a position in MDNA in Q4 2022 and held it in 3 quarters. The position peaked at $20K in Q4 2022. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

Virtu Financial reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
Virtu Financial sold 12,086 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $3K.
Virtu Financial first reported a position in Medicenna Therapeutics Corp. Common Shares in Q4 2022 and held it in 3 quarters.
Virtu Financial's Medicenna Therapeutics Corp. Common Shares position peaked at $20K in Q4 2022.
3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.